Evidence map›Paper›PMID 29378654›Full record

ArticleActa neuropathologica communications2018

Exceptional in vivo catabolism of neurodegeneration-related aggregates.

Zsolt Datki, Zita Olah, Tibor Hortobagyi, Lilla Macsai, Katalin Zsuga, Livia Fulop, Zsolt Bozso, Bence Galik, Eva Acs, Angela Foldi and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Acta neuropathologica communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Zsolt DatkiDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Kalvaria sgt. 57, Szeged, H-6725, Hungary. datki.zsolt@med.u-szeged.hu.ORCID 0000-0002-2537-4741
Zita OlahDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Kalvaria sgt. 57, Szeged, H-6725, Hungary.
Tibor HortobagyiMTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neuropathology, Institute of Pathology, University of Debrecen, P.O. Box 24, Debrecen, H-4012, Hungary.
Lilla MacsaiDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Kalvaria sgt. 57, Szeged, H-6725, Hungary.
Katalin ZsugaAgrint Kft., Facan sor 56, Godollo, H-2100, Hungary.
Livia FulopDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Semmelweis u. 6, Szeged, H-6725, Hungary.
Zsolt BozsoDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Semmelweis u. 6, Szeged, H-6725, Hungary.
Bence GalikBioinformatics & Scientific Computing, Vienna Biocentre Core Facilities, Dr. Bohr-Gasse 3, 1030, Vienna, Austria.
Eva AcsDanube Research Institute, MTA Centre for Ecological Research, Karolina ut 29-31, Budapest, H-1113, Hungary.
Angela FoldiSustainable Ecosystems Group, MTA Centre for Ecological Research, Klebelsberg Kuno u. 3, Tihany, H-8237, Hungary.
Amanda SzarvasDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Kalvaria sgt. 57, Szeged, H-6725, Hungary.
Janos KalmanDepartment of Psychiatry, Faculty of Medicine, University of Szeged, Kalvaria sgt. 57, Szeged, H-6725, Hungary.
University of Szeged · HUDanube Research Institute · HUHUN-REN Centre for Ecological Research · HUUniversity of Debrecen · HUVienna Biocenter · AT

Funding

GINOP 2.3.2-15-2016-00019
6 · The paper itself

Abstract

Neurodegenerative diseases are linked to a systemic enzyme resistance of toxic aggregated molecules and their pathological consequences. This paper presents a unique phenomenon that Philodina acuticornis, a bdelloid rotifer, is able to catabolize different types of neurotoxic peptide and protein aggregates (such as beta-amyloids /Aβ/, alpha-synuclein, and prion) without suffering any damage. P. acuticornis is capable of using these aggregates as an exclusive energy source (i.e., as 'food', identified in the digestive system and body) in a hermetically isolated microdrop environment, increasing their survival. As regards Aβ1-42, five other bdelloid rotifer species were also found to be able to perform this phenomenon. Based on our experiments, the Aβ1-42-treated bdelloid rotifers demonstrate significantly increased survival (e.g. mean lifespan = 51 ± 2.71 days) compared to their untreated controls (e.g. mean lifespan = 14 ± 2.29 days), with similar improvements in a variety of phenotypic characteristics. To our knowledge, no other animal species have so far been reported to have a similar capability. For all other microscopic species tested, including monogonant rotifers and non-rotifers, the treatment with Aβ1-42 aggregates proved to be either toxic or simply ineffective. This paper describes and proves the existence of an unprecedented in vivo catabolic capability of neurotoxic aggregates by bdelloid rotifers, with special focus on P. acuticornis. Our results may provide the basis for a new preclinical perspective on therapeutic research in human neurodegenerative diseases.

Indexed as

Amyloid beta-PeptidesAnimalsCaenorhabditis elegansCell Line, TumorHumansKaplan-Meier EstimateLoboseaMetabolismNeurodegenerative DiseasesOligohymenophoreaPlatyhelminthsProtein Aggregation, PathologicalRotiferaSpecies SpecificityTardigradaAmyloid beta-PeptidesAlpha-synucleinBdelloid rotiferBeta-amyloidCatabolismLifespanPrion

Identifiers

PMID29378654
PMCPMC5789616
OpenAlexW2786734975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.